Cargando…
Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis
INTRODUCTION: Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) are rare inherited retinal degenerative disorders. The Visual Symptom and Impact Outcomes patient-reported outcome (ViSIO-PRO) and observer-reported outcome (ViSIO-ObsRO) instruments were developed in this population to ass...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011359/ https://www.ncbi.nlm.nih.gov/pubmed/36847938 http://dx.doi.org/10.1007/s40123-023-00670-8 |
_version_ | 1784906374340149248 |
---|---|
author | Fischer, M. Dominik Patalano, Francesco Naujoks, Christel Banhazi, Judit Bouchet, Christine O’Brien, Paul Kay, Christine Green, Jane Durham, Todd Bradley, Helena Williamson, Nicola Barclay, Melissa Sims, Joel Audo, Isabelle |
author_facet | Fischer, M. Dominik Patalano, Francesco Naujoks, Christel Banhazi, Judit Bouchet, Christine O’Brien, Paul Kay, Christine Green, Jane Durham, Todd Bradley, Helena Williamson, Nicola Barclay, Melissa Sims, Joel Audo, Isabelle |
author_sort | Fischer, M. Dominik |
collection | PubMed |
description | INTRODUCTION: Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) are rare inherited retinal degenerative disorders. The Visual Symptom and Impact Outcomes patient-reported outcome (ViSIO-PRO) and observer-reported outcome (ViSIO-ObsRO) instruments were developed in this population to assess visual function symptoms and impacts on vision-dependent activities of daily living (ADL) and distal health-related quality of life (HRQoL). This study aimed to explore the psychometric properties of the ViSIO-PRO and ViSIO-ObsRO in RP/LCA. METHODS: The 49-item ViSIO-PRO and 27-item ViSIO-ObsRO instruments were completed by 83 adult and adolescent patients and 22 caregivers of child patients aged 3–11 years with RP/LCA, respectively, at baseline and 12–16-day follow-up. Concurrent measures were also administered at baseline. Psychometric analyses assessed item (question) properties, dimensionality, scoring, reliability, validity, and score interpretation. RESULTS: Item responses were mainly evenly distributed across the response scale, and inter-item correlations were mostly moderate to strong (> 0.30) at baseline within hypothesized domains. Item deletion was informed by item properties, qualitative data, and clinical input and supported retention of 35 ViSIO-PRO items and 25 ViSIO-ObsRO items. Confirmatory factor analysis in line with pre-hypothesized domains supported a four-factor model assessing visual function symptoms, mobility, vision-dependent ADL, and distal HRQoL. A bifactor model supported calculation of total scores and four domain scores. Internal consistency was high for domain and total scores (Cronbach’s alpha > 0.70) and test–retest reliability for total scores was strong between baseline and 12–16-day follow-up (intraclass correlation coefficients 0.66–0.98). Convergent validity was supported by strong correlations in a logical pattern with concurrent measures. Mean baseline scores differed significantly between severity groups. Distribution-based methods provided initial insights to guide interpretation of scores. CONCLUSIONS: Findings supported item reduction and established scoring of the instruments. Evidence of reliability and validity as outcome measures in RP/LCA was also reported. Further research is ongoing to explore responsiveness of the ViSIO-PRO and ViSIO-ObsRO instruments and interpretation of change scores. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40123-023-00670-8. |
format | Online Article Text |
id | pubmed-10011359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-100113592023-03-15 Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis Fischer, M. Dominik Patalano, Francesco Naujoks, Christel Banhazi, Judit Bouchet, Christine O’Brien, Paul Kay, Christine Green, Jane Durham, Todd Bradley, Helena Williamson, Nicola Barclay, Melissa Sims, Joel Audo, Isabelle Ophthalmol Ther Original Research INTRODUCTION: Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) are rare inherited retinal degenerative disorders. The Visual Symptom and Impact Outcomes patient-reported outcome (ViSIO-PRO) and observer-reported outcome (ViSIO-ObsRO) instruments were developed in this population to assess visual function symptoms and impacts on vision-dependent activities of daily living (ADL) and distal health-related quality of life (HRQoL). This study aimed to explore the psychometric properties of the ViSIO-PRO and ViSIO-ObsRO in RP/LCA. METHODS: The 49-item ViSIO-PRO and 27-item ViSIO-ObsRO instruments were completed by 83 adult and adolescent patients and 22 caregivers of child patients aged 3–11 years with RP/LCA, respectively, at baseline and 12–16-day follow-up. Concurrent measures were also administered at baseline. Psychometric analyses assessed item (question) properties, dimensionality, scoring, reliability, validity, and score interpretation. RESULTS: Item responses were mainly evenly distributed across the response scale, and inter-item correlations were mostly moderate to strong (> 0.30) at baseline within hypothesized domains. Item deletion was informed by item properties, qualitative data, and clinical input and supported retention of 35 ViSIO-PRO items and 25 ViSIO-ObsRO items. Confirmatory factor analysis in line with pre-hypothesized domains supported a four-factor model assessing visual function symptoms, mobility, vision-dependent ADL, and distal HRQoL. A bifactor model supported calculation of total scores and four domain scores. Internal consistency was high for domain and total scores (Cronbach’s alpha > 0.70) and test–retest reliability for total scores was strong between baseline and 12–16-day follow-up (intraclass correlation coefficients 0.66–0.98). Convergent validity was supported by strong correlations in a logical pattern with concurrent measures. Mean baseline scores differed significantly between severity groups. Distribution-based methods provided initial insights to guide interpretation of scores. CONCLUSIONS: Findings supported item reduction and established scoring of the instruments. Evidence of reliability and validity as outcome measures in RP/LCA was also reported. Further research is ongoing to explore responsiveness of the ViSIO-PRO and ViSIO-ObsRO instruments and interpretation of change scores. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40123-023-00670-8. Springer Healthcare 2023-02-27 2023-04 /pmc/articles/PMC10011359/ /pubmed/36847938 http://dx.doi.org/10.1007/s40123-023-00670-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Fischer, M. Dominik Patalano, Francesco Naujoks, Christel Banhazi, Judit Bouchet, Christine O’Brien, Paul Kay, Christine Green, Jane Durham, Todd Bradley, Helena Williamson, Nicola Barclay, Melissa Sims, Joel Audo, Isabelle Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis |
title | Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis |
title_full | Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis |
title_fullStr | Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis |
title_full_unstemmed | Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis |
title_short | Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis |
title_sort | psychometric validation of the visio-pro and visio-obsro in retinitis pigmentosa and leber congenital amaurosis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011359/ https://www.ncbi.nlm.nih.gov/pubmed/36847938 http://dx.doi.org/10.1007/s40123-023-00670-8 |
work_keys_str_mv | AT fischermdominik psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT patalanofrancesco psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT naujokschristel psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT banhazijudit psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT bouchetchristine psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT obrienpaul psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT kaychristine psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT greenjane psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT durhamtodd psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT bradleyhelena psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT williamsonnicola psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT barclaymelissa psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT simsjoel psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis AT audoisabelle psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis |